Rubio Sends Letter to Pfizer CEO on Alleged Gain-of-Function ... - dofaq.co
Rubio Sends Letter to Pfizer CEO on Alleged Gain-of-Function ...
BridgeBio heart drug approved by FDA, setting up battle with Pfizer
Pfizer replaces retiring CSO with cancer chief—Chutes & Ladders
Pfizer’s new R&D head, a VC deep-dive, and a new FDA commissioner?
FDA approves BridgeBio’s heart disease drug, setting up competition with Pfizer, Alnylam
These 4 Measures Indicate That Pfizer (NYSE:PFE) Is Using Debt Extensively
As other Big Pharmas face local headwinds, Pfizer doubles down on China commitment with Zai Lab antimicrobial marketing pact
Zai Lab and Pfizer to commercialise XACDURO in China
Pfizer Inc. (NYSE:PFE) Shares Sold by Summit Trail Advisors LLC
Pfizer Stock Drops 10% In November On News Of Kennedy's HHS Nomination - Pfizer (NYSE:PFE)
Pfizer: High Dividend And Low Price Might Still Offset The Expanding Risks (NYSE:PFE)
Comparing the COVID-19 Vaccines: How Are They Different?
BridgeBio Wins FDA Approval for ATTR-CM Drug, Launching Competition with Pfizer
Is Pfizer Stock A Sell After Covid Products Drive Surprise Upside?
Pfizer names oncology head Chris Boshoff as R&D chief
Pfizer Announces New Chief Scientific Officer and President, Research & Development
Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer
Pfizer Names New R&D Chief
Pfizer, Flagship return to obesity as part of latest additions to multibillion-dollar collaboration
Pfizer (NYSE:PFE) stock falls 5.3% in past week as three-year earnings and shareholder returns continue downward trend
